Cytosorbents Corporation Stock News

MONMOUTH JUNCTION, N.J., Feb. 8, 2022 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surge

CytoSorbents Corp (NASDAQ: CTSO ) reported preliminary Q4 FY21 revenue of approximately $10.8 million , better than the consensus of $9.58 million. It reported revenue of $12.0 million in Q4 2020. The company expects blended product gross margins to be approximately 80% for Q4 Full story available on Benzinga.com

CytoSorbents Corp (NASDAQ: CTSO) reported preliminary Q4 FY21 revenue of approximately $10.8 million, better than the consensus of $9.58 million. It reported revenue of $12.0 million in Q4 2020.

Cytosorbents Corp (CTSO) shares closed today at 1.3% above its 52 week low of $3.18, giving the company a market cap of $139M. The stock is currently down 23.2% year-to-date, down 63.5% over the past 12 months, and down 44.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 59.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1069.0% The company's stock price performance over the past 12 months lags the peer average by 815.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cytosorbents Corp (CTSO) shares closed today 10.1% lower than it did at the end of yesterday. The stock is currently down 23.2% year-to-date, down 63.5% over the past 12 months, and down 44.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $4.09 and as low as $3.18 this week.Shares closed 72.4% below its 52-week high and 1.3% above its 52-week low.Trading volume this week was 49.8% lower than the 10-day average and 59.6% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1069.0% The company's stock price performance over the past 12 months lags the peer average by 815.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cytosorbents Corp (CTSO) shares closed today at 0.3% above its 52 week low of $3.86, giving the company a market cap of $168M. The stock is currently down 7.6% year-to-date, down 54.6% over the past 12 months, and down 32.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 29.2% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 376.1% The company's stock price performance over the past 12 months lags the peer average by 1104.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cytosorbents Corp (CTSO) shares closed 1.7% lower than its previous 52 week low, giving the company a market cap of $190M. The stock is currently down 45.0% year-to-date, down 47.3% over the past 12 months, and down 23.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 2.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 3347.7% The company's stock price performance over the past 12 months lags the peer average by 2224.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cytosorbents Corp (CTSO) shares closed today at 1.9% above its 52 week low of $4.25, giving the company a market cap of $188M. The stock is currently down 45.7% year-to-date, down 49.4% over the past 12 months, and down 19.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 47.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2061.6% The company's stock price performance over the past 12 months lags the peer average by 1759.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cytosorbents Corp (CTSO) shares closed today at 0.5% above its 52 week low of $4.26, giving the company a market cap of $185M. The stock is currently down 46.5% year-to-date, down 49.8% over the past 12 months, and down 14.8% over the past five years. This week, the Dow Jones Industrial Average fell 2.0%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 39.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2032.8% The company's stock price performance over the past 12 months lags the peer average by 1710.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Market Snapshot A recently published report by QY Research, titled Global Systemic Inflammatory Response Syndrome Treatment Market Size, Status and Forecast 2022 gives an overview of the overall Systemic Inflammatory Response Syndrome Treatment market. This section sheds light on key

MONMOUTH JUNCTION, N.J., Nov. 15, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery

CytoSorbents Corporation (CTSO) CEO Phillip Chan on Q3 2021 Results - Earnings Call Transcript

The stock price of Cytosorbents Corp (NASDAQ: CTSO) increased by over 6% pre-market today. This is why it happened.

MONMOUTH JUNCTION, N.J., Oct. 14, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using

MONMOUTH JUNCTION, N.J., Oct. 12, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blo